REGN2810

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN2810, covering 2022-11-03 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers [Phase 1]